A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)

Clinical trial NCT00292266 · COMPLETED

Trial details

NCT number: NCT00292266
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 1999-11-01
Primary completion: 2002-06-01
Enrollment: 677

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.